跳至主要内容
临床试验/NCT00756405
NCT00756405已完成不适用

Potential Health Benefits of Dietary Antioxidants From Supplements v. Foods

Christopher Gardner2 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2007年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
88
试验地点
2
主要终点
Change from baseline in inflammatory Markers [monocyte chemotactic protein-1 (MCP-1), interleukin-6 (IL-6), and soluble intercellular adhesion molecule-1 (sICAM-1)] at 8 weeks

研究概览

简要总结

The aim of the Antioxidant Study was to compare the efficacy of foods naturally rich in antioxidants with that of antioxidants in a pill form on markers of inflammation and plasma cholesterol in healthy adults at risk of cardiovascular disease.

详细描述

Increasing the amount of antioxidants in your diet is thought to be one way to improve your health. If antioxidants do have a beneficial effect, one way to measure that is to examine possible changes in the levels of inflammatory markers in your blood.

Participants were asked to consume an antioxidant supplement including carotenoids, mixed tocopherols, vitamin C and selenium, or a placebo for 8 weeks. The doses of antioxidants will be similar to the amounts suggested by the United States Department of Agriculture (USDA) recommended daily allowances (RDA). In addition, a group of participants will be asked to change their usual eating habits and consume more of certain foods that are naturally good sources of the four antioxidants contained in the pills.

Eligible participants were asked to come to the Stanford Campus for 3 fasting blood draws over the period of 8 weeks and to complete diet and physical activity questionnaires at the beginning, middle, and end of the study period.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Overweight/obesity; high LDL cholesterol, pre-hypertension.

排除标准

  • Daily intake of > 5 servings of vegetables and fruits
  • Fasting blood glucose >140 mg/dL
  • Liver or renal disease; Atherosclerosis (e.g., CAD, PAD); Malignant neoplasm; Ongoing infection; Inflammatory disease 5.Currently taking the following medications: Anti-inflammatory drugs Lipid lowering drugs Anti-hypertensive drugs Calcium containing drugs Drugs known to affect blood coagulation Drugs known to affect antioxidant status
  • Pregnant or lactating
  • Inability to communicate effectively with study staff

结局指标

主要结局

Change from baseline in inflammatory Markers [monocyte chemotactic protein-1 (MCP-1), interleukin-6 (IL-6), and soluble intercellular adhesion molecule-1 (sICAM-1)] at 8 weeks

时间窗: Baseline and 8 weeks

Change was calculated as the value at 8 weeks minus the value at baseline

次要结局

  • Dietary antioxidants(Baseline and 8 weeks)
  • Blood concentrations of antioxidants at baseline and 8 weeks(Baseline and 8 weeks)

研究者

发起方
Christopher Gardner
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Christopher Gardner

Professor of Medicine (Research)

Stanford University

研究点 (2)

Loading locations...

相似试验